Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 1 | 1 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0021 | 0 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0021 | 0 | 0.5 |
Brugia malayi | Unc-6 protein precursor | 0.0024 | 0.03 | 0.03 |
Brugia malayi | Fibroblast growth factor family protein | 0.0063 | 0.4406 | 0.4406 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.03 | 0.03 |
Brugia malayi | Fibroblast growth factor family protein | 0.0063 | 0.4406 | 0.4406 |
Onchocerca volvulus | 0.0032 | 0.1156 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.4406 | 0.4406 |
Loa Loa (eye worm) | bone morphogenic protein 6 | 0.0064 | 0.4488 | 0.4488 |
Leishmania major | hypothetical protein, conserved | 0.0021 | 0 | 0.5 |
Brugia malayi | Transforming growth factor beta like domain containing protein | 0.0064 | 0.4488 | 0.4488 |
Schistosoma mansoni | netrin | 0.0024 | 0.03 | 1 |
Echinococcus granulosus | anti dorsalizing morphogenetic protein 1a | 0.0064 | 0.4488 | 1 |
Schistosoma mansoni | netrin | 0.0024 | 0.03 | 1 |
Giardia lamblia | Hypothetical protein | 0.0063 | 0.4406 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.4406 | 0.4406 |
Toxoplasma gondii | kringle domain-containing protein | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | netrin 1 | 0.0024 | 0.03 | 0.0669 |
Echinococcus granulosus | netrin 1 | 0.0024 | 0.03 | 0.0669 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0021 | 0 | 0.5 |
Echinococcus multilocularis | anti dorsalizing morphogenetic protein 1a | 0.0064 | 0.4488 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 1000 uM | Inhibitory activity against human platelet aggregation. | ChEMBL. | 7837229 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.